Found 16 matching trials
Treatment for Patients With Multiple Hepatocellular Carcinomas Based on the NDR Scoring System NA The aim of this study is to establish a selection criteria of hepatectomy f...
Show More Location
Eastern hepatobilliary surgery hospital
Learn More & Join Trial
Emulsion Versus Suspension in Chemoembolization for Hepatocellular Carcinoma NA The aim of the study was to evaluate the safety and efficacy of using the n...
Show More Location
Department of Imaging and Interventional Radiology, Prince of Wales Hospital, The Chinese University of Hong Kong
Learn More & Join Trial
Efficacy and Safety of Raltitrexed-based Transarterial Chemoembolisation(TACE)for Colorectal Cancer Liver Metastases PHASE4 To evaluate the efficacy and safety of Raltitrexed for advanced colorectal ...
Show More Location
Zhongshan Hospital Fudan University
Learn More & Join Trial
TACE Plus Camrelizumab and Apatinib for Unresectable Hepatocellular Carcinoma PHASE3 Hepatocellular carcinoma (HCC) is the sixth most common cancer and the thir...
Show More Location
Sichuan Cancer Hospital and Research Institute
Learn More & Join Trial
Toripalimab Plus Bevacizumab Combined Three Intra-arterial Therapies (TACE, HAIC, or TACE-HAIC) for Unresectable Hepatocellular Carcinoma: a Phase 2, Multicenter Randomised Non-comparative Trial PHASE2 Toripalimab and bevacizumab (T-B) was approve for unresectable hepatocellul...
Show More Status
Active Not Recruiting
Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Comparison of SBRT and SIRT With Combination IO for Locally-advanced, Unresectable HCCs (BIIRTH) PHASE2 The goal of this clinical trial is to compare the safety and efficacy of se...
Show More Location
Tuen Mun Hospital
Learn More & Join Trial
HAIC Combined With Second-line "Target Immunity" for HCC With TACE Standard Treatment Low Response or Failure NA This study is a prospective, randomized controlled, multicenter clinical st...
Show More Location
Multiple Locations
Learn More & Join Trial
Atezolizumab Plus Bevacizumab Versus Sintilimab Plus Bevacizumab With TACE and HAIC in Unresectable Hepatocellular Carcinoma N/A Systemic therapy is the primary option for managing advanced hepatocellular...
Show More Learn More & Join Trial
Can Quantitative MRI After cTACE Help Predict Survival ? N/A Transcatheter arterial chemoembolization (TACE) is a widely accepted pallia...
Show More Location
Medical College of Wisconsin/Froedtert Memorial Lutheran Hospital
Learn More & Join Trial
DEB-TACE vs. cTACE as Conversion Therapy for Unresectable Large HCC NA This study is conducted to evaluate the efficacy of drug-eluting bead trans...
Show More Location
the Second Affiliated Hospital of Guangzhou Medical University
Learn More & Join Trial